Rubfila International Ltd

PTIL divestment details

• Board approved sale of Rubfila's entire stake in Premier Tissues India Limited.
• Aggregate consideration fixed at €61.00 crore.
• Proposed purchaser is Finquest Personal Care Pvt. Ltd.
• Payment to be made within 30 days after shareholder or regulatory approvals.
• Transaction on an as-is, no further due diligence.
• Subject to requisite shareholder and other statutory/regulatory approvals.
• Hardik Patel recused from deliberations due to related-party status.
• Valuation reports from two independent valuers considered.
• PTIL will cease to be Rubfila's subsidiary on completion.
• Execution of transaction documents and disclosures to exchanges to be completed.
• Board authorized officers to undertake actions and disclosures.

PTIL financials & execution timeline

• PTIL turnover for year ended 31-03-2026: ₹95.74 crore.
• PTIL net worth as of 31-03-2026: ₹51.49 crore.
• PTIL contributed 15.68% of Rubfila's consolidated revenue.
• Execution documents expected by 10-09-2026.

Governance & approvals

• Shareholder approvals and other statutory/regulatory approvals required.
• 33rd AGM scheduled for 29 September 2026 at 11:00 AM.
• Board authorized Company Secretary to complete disclosures and filings.

Regulatory & completion timeline

• Divestment subject to Companies Act 2013 and SEBI LODR compliance.
• Transaction completion within 30 days of approvals.

Key financial results approved

• Unaudited standalone results for quarter ended 30 June 2026 approved.
• Unaudited consolidated results for quarter ended 30 June 2026 approved.
• Limited Review Reports for both standalone and consolidated results approved.
• Standalone and consolidated balance sheets and cash flows included in results.

Auditor remarks and contingencies

• Provision for Contingencies balance of 11,379.00 lakhs as at 30 June 2026.
• Auditors provide a qualified conclusion due to contingency provision; not recognised per Ind AS 37.
• If the quarterly provision were not recognised, standalone PBT would rise by 30.00 lakhs.
• Consolidated results include Premier Tissues India Limited; reported by other auditors.

Resignation details

• Bharat J. Dattani, Non-Executive Director, resigning.
• Effective date of resignation: 6 July 2026 (cessation per Annexure A).
• Reason for resignation: provided in Annexure A per SEBI circular.
• No additional material reasons disclosed beyond Annexure A.
• Resignation accepted by Non-Executive Chairman on 16 July 2026.

demat/remat processing

• Securities for dematerialisation during quarter ended 30 June 2026 were confirmed as accepted/rejected and listed on stock exchanges.
• Physical dematerialisation certificates were mutilated and cancelled after verification; depository name substituted as registered owner within 15 days.